Cargando…

Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group

OBJECTIVE: We evaluated pseudoprogression (PsPD) following radiation therapy combined with concurrent temozolomide (TMZ), and we assessed pseudoresponse following anti-angiogenic therapy for patients with recurrent disease using the Response Assessment of the Neuro-Oncology Working Group. METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ji Hyun, Kim, Chae-Yong, Choi, Byung Se, Kim, Yu Jung, Kim, Jae Sung, Kim, In Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Neurosurgical Society 2014
Materias:	Clinical Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928350/ https://www.ncbi.nlm.nih.gov/pubmed/24570811 http://dx.doi.org/10.3340/jkns.2014.55.1.5

Ejemplares similares

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
por: Zikou, Anastasia, et al.
Publicado: (2018)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
por: Kim, Young Zoon, et al.
Publicado: (2019)

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
por: Kim, Young Zoon, et al.
Publicado: (2019)

IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP
por: Erker, Craig, et al.
Publicado: (2020)

Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
por: YOO, Roh-EUL, et al.
Publicado: (2015)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

IMG-03. RESPONSE ASSESSMENT IN PEDIATRIC LOW-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP
por: Fangusaro, Jason, et al.
Publicado: (2020)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma()
por: Bronk, Julianna K., et al.
Publicado: (2018)

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
por: Abbasi, Abdul W., et al.
Publicado: (2017)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis
por: Taylor, Chris, et al.
Publicado: (2022)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse
por: Arevalo, Octavio D., et al.
Publicado: (2019)

Yesterdays, Todays, and Tomorrows—Korean Society for Pediatric Neuro-Oncology(*)
por: Kim, Se Hoon
Publicado: (2023)

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
por: Jang, Bum-Sup, et al.
Publicado: (2018)

The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
por: Yoon, Hong In, et al.
Publicado: (2021)

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021)

Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study
por: Kwon, Ji-Eyon, et al.
Publicado: (2020)

GLIOMA-07 E.R.A.S. IN NEURO-ONCOLOGY
por: Moro, Mario
Publicado: (2023)

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
por: Bernhardt, Denise, et al.
Publicado: (2020)

Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics
por: Ari, Asena Petek, et al.
Publicado: (2022)

The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis
por: Zhou, Min, et al.
Publicado: (2019)

Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings
por: Beckmann, K. R., et al.
Publicado: (2017)

The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
por: Kim, Young Zoon, et al.
Publicado: (2019)

Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning
por: Lee, Joonsang, et al.
Publicado: (2020)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

LGG-52. Volumetry-based response characterization of recurrent pediatric low-grade gliomas in PNOC clinical Neuro-oncology trials
por: von Reppert, Marc, et al.
Publicado: (2022)

Molecular Biology in Treatment Decision Processes—Neuro-Oncology Edition
por: Krauze, Andra V., et al.
Publicado: (2021)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm
por: Gerges, Noha, et al.
Publicado: (2013)

A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran
por: Ansari, Mansour, et al.
Publicado: (2017)

Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group
por: AOKI, Tomokazu, et al.
Publicado: (2017)

Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma
por: Lazaridis, Lazaros, et al.
Publicado: (2022)

The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis
por: Wan, Bing, et al.
Publicado: (2017)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review
por: Ius, Tamara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d61pgeinflhl4gen4i84jav3da